| |
| |
|
| Insider
Information: |
Hagen Steven R |
| Relationship: |
SVP Manufacturing & Ph... |
| City: |
Albany |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Albany Molecular Research Inc |
AMRI |
SVP Manufacturing & Ph... |
2017-08-31 |
0 |
2008-11-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
124 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2012-11-05 |
4 |
S |
$3.51 |
$1,306 |
D/D |
(372) |
27,870 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-01-31 |
4 |
A |
$5.99 |
$59,900 |
D/D |
10,000 |
37,870 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-02-19 |
4 |
S |
$7.89 |
$7,890 |
D/D |
(1,000) |
36,870 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-02-22 |
4 |
S |
$8.18 |
$8,049 |
D/D |
(984) |
35,886 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-07 |
4 |
S |
$9.56 |
$9,560 |
D/D |
(1,000) |
34,886 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-12 |
4 |
S |
$10.75 |
$7,278 |
D/D |
(677) |
34,209 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-18 |
4 |
S |
$9.98 |
$2,485 |
D/D |
(249) |
33,960 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-03-19 |
4 |
S |
$9.91 |
$1,784 |
D/D |
(180) |
33,780 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-05-10 |
4 |
S |
$10.40 |
$12,480 |
D/D |
(1,200) |
32,580 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-05-29 |
4 |
S |
$11.26 |
$9,008 |
D/D |
(800) |
31,780 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,250) |
30,530 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(454) |
30,076 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-11-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(362) |
29,714 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-11-22 |
4 |
S |
$11.55 |
$26,565 |
D/D |
(2,300) |
27,414 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-12-04 |
4 |
OE |
$2.93 |
$7,325 |
D/D |
2,500 |
29,914 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2013-12-04 |
4 |
S |
$10.93 |
$27,325 |
D/D |
(2,500) |
27,414 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,038) |
26,376 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-04 |
4 |
A |
$10.43 |
$130,375 |
D/D |
12,500 |
38,876 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,038) |
37,838 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-19 |
4 |
S |
$13.37 |
$20,055 |
D/D |
(1,500) |
36,338 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-21 |
4 |
S |
$14.87 |
$22,305 |
D/D |
(1,500) |
34,838 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-25 |
4 |
S |
$15.19 |
$37,975 |
D/D |
(2,500) |
34,838 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-25 |
4 |
OE |
$2.93 |
$7,325 |
D/D |
2,500 |
37,338 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-27 |
4 |
OE |
$9.34 |
$28,020 |
D/D |
3,000 |
37,838 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-27 |
4 |
S |
$15.73 |
$47,190 |
D/D |
(3,000) |
34,838 |
0 |
- |
|
124 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
